★ America V2AuditLine ALPHA

AuditLine › HHS OIG › Food and Drug Administration

HHS OIG recommendation 20-E-01-044.03

FDA should enhance its Risk Evaluation and Mitigation Strategy (REMS) assessment review process.

Closed ImplementedThe publisher's status, as reported by HHS Office of Inspector General in the file read .

The recommendation, in the publisher's words

FDA should enhance its Risk Evaluation and Mitigation Strategy (REMS) assessment review process.
Responsible agency
Food and Drug Administration
Issued
September 25, 2020
Report
FDA's Risk Evaluation and Mitigation Strategies: Uncertain Effectiveness in Addressing the Opioid Crisis (OEI-01-17-00510) · find it at HHS OIG
Kind of report
Evaluation
Agency response
Concur (as recorded by the publisher)
Closed
March 31, 2025 (publisher's date)
Publisher topics
Food; Drug and Device Safety, Prescription Drug, Public Health Issues, Substance Abuse Disorder

“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.

Dated history

  1. Issued by HHS OIG. (publisher's date)
  2. Closed, with status “Closed Implemented”. (publisher's date)
  3. First recorded by AuditLine. (start of AuditLine's own history for this record)

Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.

Other recommendations from this report

3 more, of which 0 are open in the publisher's file.

Source

Open this report in HHS OIG's tracker This publisher's records (CSV)

Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows, SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.